ApprovalTrail

Approval · Notice of Compliance 10185 · 2009

ZEMURON: Notice of Compliance 10185

Issued April 30, 2009

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
10185
Date
April 30, 2009
Company
Organon Canada Inc.Kirkland, Quebec, Canada
Product type
Prescription Pharmaceutical
Submission
Supplement to a New Drug Submission (SNDS), supplement
Submission class
Other
Reason
Updates to the Clinical Trials section of the Product Monograph and other revisions to the PM
Therapeutic class
Non-depolarizing skeletal neuromuscular blocking agent

Products in this notice

BrandDINStatus today
ZEMURONNot yet assigned—

Medicinal ingredients